The Current Ratio as of September 2024 (TTM) for Accuray Incorporated (ARAY) is 1.65

According to Accuray Incorporated’s latest financial reports and current stock price. The company's current Current Ratio is 1.65. This represents a change of 2.23% compared to the average of 1.61 of the last 4 quarters.

Accuray Incorporated (ARAY) Historical Current Ratio (quarterly & annually)

How has ARAY Current Ratio performed in the past?

The mean historical Current Ratio of Accuray Incorporated over the last ten years is 1.72. The current 1.65 Current Ratio has changed 9.51% with respect to the historical average. Over the past ten years (40 quarters), ARAY's Current Ratio was at its highest in in the March 2015 quarter at 2.10. The Current Ratio was at its lowest in in the March 2017 quarter at 1.05.

Accuray Incorporated (ARAY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Accuray Incorporated Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Accuray Incorporated (ARAY) Average Current Ratio

How has ARAY Current Ratio performed in the past?

The current Current Ratio of Accuray Incorporated (ARAY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Accuray Incorporated (ARAY) Current Ratio vs. Peers

How is ARAY’s Current Ratio compared to its peers?

Accuray Incorporated’s Current Ratio is less than Surmodics, Inc. (3.98), less than AxoGen, Inc. (3.51), greater than Bioventus Inc. (1.33), less than Cutera, Inc. (3.51), greater than NuVasive, Inc. (1.25), less than Paragon 28, Inc. (3.57), less than Orthofix Medical Inc. (2.48), less than SI-BONE, Inc. (9.17), less than Avanos Medical, Inc. (2.28), greater than Aziyo Biologics, Inc. (0.87), less than Apyx Medical Corporation (5.33), greater than INVO Bioscience, Inc. (0.30), less than Artivion, Inc. (4.63), less than Anika Therapeutics, Inc. (5.93), less than Sight Sciences, Inc. (11.01), less than Cytosorbents Corporation (2.12), less than NeuroPace, Inc. (6.37), less than ClearPoint Neuro, Inc. (2.79), less than TELA Bio, Inc. (3.41), less than OrthoPediatrics Corp. (4.90),

Build a custom stock screener for Accuray Incorporated (ARAY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Accuray Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Accuray Incorporated (ARAY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Accuray Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.